Endometriosis-Associated Ovarian Cancer: What Are the Implications for Women with Intact Endometrioma Planning for a Future Pregnancy? A Reproductive Clinical Outlook

Biomolecules. 2022 Nov 21;12(11):1721. doi: 10.3390/biom12111721.

Abstract

Endometriosis is a chronic, universal, and prevalent disease estimated to affect up to 1:10 women of reproductive age. Endometriosis-associated ovarian cancer (EAOC) developing at reproductive age is challenging and of concern for women and practitioners alike. This outlook review focuses on the occurrence of EAOC, especially in infertile women or those planning for a future pregnancy, from the perspective of a reproductive endocrinologist, based on recent evidence. Contemporary pathogenesis, genetic profiles, evidence of causality, clinical diagnosis, prognosis, and up-to-date management are discussed. EAOC seems to be merely associated with endometrioma and includes clear-cell and endometrioid ovarian carcinoma. Although endometrioma is frequently found in women of reproductive age (up to 1:18 of women), EAOC appears to be a rare occurrence. These women are of more advanced reproductive age, nulliparous, and hyperestrogenic, with a large-sized unilateral endometrioma (>9 cm) containing solid components and papillary projections. Each case suspected to have EAOC has specific characteristics, and a multidisciplinary discussion and appropriate patient counseling should be conducted to reach an optimal therapeutic plan. Since most of these cases are diagnosed at an early stage with a favorable prognosis, fertility-sparing surgery may be feasible. The pros and cons of fertility preservation techniques should be discussed.

Keywords: clear-cell ovarian carcinoma; endometrioid ovarian carcinoma; endometrioma; endometriosis; endometriosis-associated ovarian cancer; genetic profiles; magnetic resonance imaging; ovarian reserve; ovarian reserve biomarkers; reproductive age; transvaginal ultrasound.

Publication types

  • Review

MeSH terms

  • Carcinoma, Ovarian Epithelial
  • Endometriosis* / complications
  • Female
  • Humans
  • Infertility, Female*
  • Ovarian Neoplasms* / complications
  • Pregnancy
  • Reproduction

Grants and funding

This research received no external funding.